People who take weight-loss drugs based on GLP-1 receptor agonists seem to have reduced risk for a litany of diseases, including Alzheimer's, but an increase in some other conditions like kidney ...
A first-in-human phase I/II study of GFH375, a highly selective and potent oral KRAS G12D inhibitor in patients with KRAS G12D mutant advanced solid tumors. This is an ASCO Meeting Abstract from the ...
You may have seen the reports. Subaru is asking consumers on the brand’s website whether or not they would be interested in a manual transmission SUV, even going as far as to mention the Outback ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results